Biogen Inc (BIIB)

NASDAQ HEALTHCARE
$194.38 +6.00% RSI 55 Neutral Add Alert

Moving Averages

SMA 200
$160.46
Price above

Company Profile

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Market Cap
$25.38B
P/E Ratio
19.68
EPS
$8.79
Beta
0.162
Dividend Yield
0.00%
52-Week High
$202.41
52-Week Low
$114.66

Similar stocks in DRUG MANUFACTURERS - GENERAL

LLY
Lilly(Eli) & Company
RSI 33.0
PFE
Pfizer Inc
RSI 39.0
JNJ
Johnson & Johnson
RSI 38.0
BMY
Bristol-Myers Squibb Company
RSI 44.0
MRK
Merck & Co Inc
RSI 38.0
NVO
Novo Nordisk
RSI 56.0

Data last updated: April 11, 2026 at 9:41 AM EDT

Track BIIB for free

Get e-mail RSI alerts when Biogen Inc enters oversold or overbought territory. Free forever.

Add Alert